Status: current, Defined. Date: 31-Dec 2019. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4286891000168111 | Tresos-B (aminobenzoic acid 20 mg + ascorbic acid 50 mg + betacarotene 6 mg + betaine hydrochloride 10 mg + biotin 50 microgram + calcium 11.5 mg + choline bitartrate 50 mg + chromium 4 microgram + cobalt 36 microgram + colecalciferol 2.5 microgram + copper 6 microgram + cyanocobalamin 100 microgram + dl-alpha-tocopheryl acetate 50 mg + folic acid 150 microgram + glutamine 50 mg + inositol 25 mg + iodine 31 microgram + lecithin 50 mg + lithium 112 microgram + lysine hydrochloride 50 mg + magnesium 7.8 mg + manganese 162.5 microgram + molybdenum 46.6 microgram + nicotinamide 220 mg + nicotinic acid 5 mg + pantothenic acid 91.6 mg + potassium 17 mg + pyridoxine hydrochloride 50 mg + retinol palmitate 750 microgram RE + riboflavin 20 mg + ribonucleic acid 25 mg + rubidium 18 microgram + taurine 125 mg + thiamine hydrochloride 50 mg + zinc 14.4 mg) tablet, 150 tablets, jar (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4286901000168110 | Tresos-B tablet, 150, jar | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
4286971000168117 | Tresos-B (aminobenzoic acid 20 mg + ascorbic acid 50 mg + betacarotene 6 mg + betaine hydrochloride 10 mg + biotin 50 microgram + calcium 11.5 mg + choline bitartrate 50 mg + chromium 4 microgram + cobalt 36 microgram + cholecalciferol 2.5 microgram + copper 6 microgram + cyanocobalamin 100 microgram + dl-alpha-tocopherol acetate 50 mg + folic acid 150 microgram + glutamine 50 mg + inositol 25 mg + iodine 31 microgram + lecithin 50 mg + lithium 112 microgram + lysine hydrochloride 50 mg + magnesium 7.8 mg + manganese 162.5 microgram + molybdenum 46.6 microgram + nicotinamide 220 mg + nicotinic acid 5 mg + pantothenic acid 91.6 mg + potassium 17 mg + pyridoxine hydrochloride 50 mg + retinyl palmitate 750 microgram RE + riboflavin 20 mg + ribonucleic acid 25 mg + rubidium 18 microgram + taurine 125 mg + thiamine hydrochloride 50 mg + zinc 14.4 mg) tablet, jar | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Tresos-B tablet, 150, jar | Is a | Tresos-B tablet, 150 | true | Inferred relationship | Some | ||
Tresos-B tablet, 150, jar | Is a | containered trade product pack | true | Inferred relationship | Some | ||
Tresos-B tablet, 150, jar | has container type | jar | true | Inferred relationship | Some | ||
Tresos-B tablet, 150, jar | has TP | Tresos-B | true | Inferred relationship | Some | ||
Tresos-B tablet, 150, jar | has TPUU | Tresos-B tablet | true | Inferred relationship | Some | 1266407960 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set